| RS2527956878 |
WDR35
|
Health Risk |
Likely pathogenic |
Cranioectodermal dysplasia 2, Short-rib thoracic dysplasia 7 with or without polydactyly |
| RS2527957063 |
WDR35
|
Health Risk |
Pathogenic/Likely pathogenic |
WDR35-related disorder, Cranioectodermal dysplasia 2 |
| RS2527959424 |
EPRS1
|
Health Risk |
Pathogenic |
— |
| RS2527961081 |
LYST
|
Health Risk |
Likely pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS2527963676 |
NCF2
|
Health Risk |
Pathogenic/Likely pathogenic |
Chronic granulomatous disease, Granulomatous disease |
| RS2527964072 |
NCF2
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS2527964515 |
NCF2
|
Health Risk |
Pathogenic/Likely pathogenic |
Chronic granulomatous disease, Granulomatous disease |
| RS2527964759 |
NCF2
|
Health Risk |
Likely pathogenic |
Granulomatous disease, chronic |
| RS2527966691 |
LMNA
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS2527967028 |
LMNA
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2527967845 |
LMNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1A, Dilated cardiomyopathy 1A |
| RS2527968047 |
LMNA
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth disease type 2, Cardiovascular phenotype |
| RS2527968384 |
LMNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS2527968546 |
EPRS1
|
Health Risk |
Pathogenic |
— |
| RS2527968714 |
LMNA
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2527972277 |
LMNA
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1A, Dilated cardiomyopathy 1A |
| RS2527972446 |
LMNA
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS2527972496 |
LMNA
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1A, Dilated cardiomyopathy 1A |
| RS2527972658 |
LMNA
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2527973173 |
LMNA
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS2527973222 |
LMNA
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Dilated cardiomyopathy 1A |
| RS2527973445 |
LMNA
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS2527973482 |
LYST
|
Health Risk |
Pathogenic/Likely pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS2527973813 |
LMNA
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS2527973836 |
LMNA
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS2527974074 |
LMNA
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS2527974254 |
MTR
|
Health Risk |
Pathogenic |
Methylcobalamin deficiency type cblG, Methylcobalamin deficiency type cblG |
| RS2527974360 |
LMNA
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS2527974458 |
LMNA
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS2527974593 |
EPRS1
|
Health Risk |
Pathogenic |
Leukodystrophy, hypomyelinating |
| RS2527974791 |
LMNA
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS2527974976 |
LMNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 2, Emery-Dreifuss muscular dystrophy 2 |
| RS2527976630 |
EPRS1
|
Health Risk |
Pathogenic |
— |
| RS2527976811 |
NCF2
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS2527978799 |
LMNA
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS2527980043 |
LMNA
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1A, Dilated cardiomyopathy 1A |
| RS2527980984 |
LMNA
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS2527981305 |
LMNA
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2527985163 |
MTR
|
Health Risk |
Pathogenic |
Methylcobalamin deficiency type cblG, Methylcobalamin deficiency type cblG |
| RS2527985401 |
MTR
|
Health Risk |
Pathogenic |
Methylcobalamin deficiency type cblG, Methylcobalamin deficiency type cblG |
| RS2527987101 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2527987206 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS2527987231 |
USH2A
|
Health Risk |
Likely pathogenic |
— |
| RS2527987310 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS2527987608 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS2527987698 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2527987900 |
USH2A
|
Health Risk |
Likely pathogenic |
— |
| RS2527987922 |
USH2A
|
Health Risk |
Likely pathogenic |
Usher syndrome type 2A, Usher syndrome type 2A |
| RS2527987978 |
USH2A
|
Health Risk |
Likely pathogenic |
— |
| RS2527988932 |
LMNA
|
Health Risk |
Pathogenic/Likely pathogenic |
Cardiovascular phenotype, Charcot-Marie-Tooth disease type 2 |
| RS2527989011 |
LMNA
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS2527989438 |
LMNA
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS2527990239 |
LMNA
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2527991012 |
PTPRC
|
Health Risk |
Likely pathogenic |
Immunodeficiency 104, Immunodeficiency 104 |
| RS2527991248 |
LMNA
|
Health Risk |
Likely pathogenic |
Cardiomyopathy, Cardiomyopathy |
| RS2527991951 |
LMNA
|
Health Risk |
Likely pathogenic |
Emery-Dreifuss muscular dystrophy 2, autosomal dominant |
| RS2527992407 |
LMNA
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS2527993395 |
PTPRC
|
Health Risk |
Pathogenic |
Immunodeficiency 104, Immunodeficiency 104 |
| RS2527994002 |
LYST
|
Health Risk |
Pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS2527994027 |
LMNA
|
Health Risk |
Pathogenic |
Primary dilated cardiomyopathy, Primary dilated cardiomyopathy |
| RS2527997008 |
LMNA
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS2527997071 |
LMNA
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS2527997089 |
LMNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 2, Cardiomyopathy |
| RS2527997430 |
LMNA
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS2527999623 |
LMNA
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS2527999747 |
LMNA
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS2528006468 |
LMNA
|
Health Risk |
Likely pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2528007230 |
LMNA
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2528007533 |
LMNA
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS2528009199 |
LMNA
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS2528011998 |
LMNA
|
Health Risk |
Pathogenic |
Emery-Dreifuss muscular dystrophy 2, autosomal dominant |
| RS2528012634 |
LMNA
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2528012830 |
LMNA
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS2528012899 |
LMNA
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS2528013214 |
NBAS
|
Health Risk |
Pathogenic |
— |
| RS2528013396 |
LMNA
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS2528018166 |
LMNA
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS2528018977 |
LMNA
|
Health Risk |
Pathogenic |
Dilated cardiomyopathy 1A, Dilated cardiomyopathy 1A |
| RS2528019483 |
LMNA
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS2528020132 |
USH2A
|
Health Risk |
Pathogenic |
Usher syndrome, Usher syndrome |
| RS2528020305 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2528020496 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 39, Usher syndrome type 2A |
| RS2528021632 |
NCF2
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS2528021760 |
NCF2
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS2528022418 |
NCF2
|
Health Risk |
Pathogenic |
— |
| RS2528022648 |
EPRS1
|
Health Risk |
Pathogenic |
Intellectual disability, Intellectual disability |
| RS2528030429 |
NBAS
|
Health Risk |
Pathogenic |
— |
| RS2528030864 |
NBAS
|
Health Risk |
Likely pathogenic |
NBAS-related disorder, NBAS-related disorder |
| RS2528034207 |
DMD
|
Health Risk |
Pathogenic |
— |
| RS2528034799 |
EPRS1
|
Health Risk |
Pathogenic |
Global developmental delay, Global developmental delay |
| RS2528035259 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2528035375 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS2528035439 |
NBAS
|
Health Risk |
Pathogenic |
— |
| RS2528035466 |
USH2A
|
Health Risk |
Likely pathogenic |
Usher syndrome type 2A, Usher syndrome type 2A |
| RS2528035588 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2528035765 |
USH2A
|
Health Risk |
Likely pathogenic |
— |
| RS2528035875 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2528035894 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS2528035944 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2528035971 |
USH2A
|
Health Risk |
Pathogenic |
— |